By Andrea Anderson
Two recent studies have illustrated the utility of RainDance Technologies' MethylSeq Solution, a sequencing-based cytosine methylation analysis method that relies on the company's microdroplet PCR technology to amplify targeted sites in the genome.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.
In Sciencethis week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.
The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.
Kaiser Health News reports that gene therapies could cost more than a million dollars.